<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://142-54-23-223.fusionmedialtd.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 09 Jul 2026 08:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://142-54-23-223.fusionmedialtd.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  S-8        Aclarion, Inc.                       </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Aclarion%2C+Inc.+++++++++++++++++++++++/26750431.html</link>
   <description>si-local-file:///var/storage/secattach/20260709/26750431.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Aclarion%2C+Inc.+++++++++++++++++++++++/26750431.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  S-8        Aclarion, Inc.                       </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Aclarion%2C+Inc.+++++++++++++++++++++++/26750431.html</link>
   <description>si-local-file:///var/storage/secattach/20260709/26750431.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Aclarion%2C+Inc.+++++++++++++++++++++++/26750431.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion adds Texas Spine Care Center to CLARITY trial network</title>
   <link>http://www.streetinsider.com/Corporate+News/Aclarion+adds+Texas+Spine+Care+Center+to+CLARITY+trial+network/26738223.html</link>
   <description>&lt;p&gt;Aclarion, Inc. (Nasdaq: ACON, ACONW) has added Texas Spine Care Center as a clinical site in its CLARITY trial, a 300-patient, prospective, randomized, multi-center study evaluating the company's Nociscan platform in patients undergoing surgical treatment for discogenic low back pain.&lt;/p&gt;&lt;p&gt;Texas Spine Care Center is a San Antonio-based orthopedic spine practice with two locations focused exclusively on spine care. The practice joins existing CLARITY sites including Johns Hopkins University, Northwestern Medicine, Advocate Aurora Research Institute, Texas Back Institute, Keck Medicine at USC, UHealth — University of Miami Health System, Scripps Health, and Lanman Spinal Neurosurgery.&lt;/p&gt;&lt;p&gt;&quot;Too often in spine care, we treat</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Aclarion+adds+Texas+Spine+Care+Center+to+CLARITY+trial+network/26738223.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:02:07 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	  </item>
  <item>
   <title>Aclarion adds Texas Spine Care Center to CLARITY trial network</title>
   <link>http://www.streetinsider.com/Corporate+News/Aclarion+adds+Texas+Spine+Care+Center+to+CLARITY+trial+network/26738223.html</link>
   <description>&lt;p&gt;Aclarion, Inc. (Nasdaq: ACON, ACONW) has added Texas Spine Care Center as a clinical site in its CLARITY trial, a 300-patient, prospective, randomized, multi-center study evaluating the company's Nociscan platform in patients undergoing surgical treatment for discogenic low back pain.&lt;/p&gt;&lt;p&gt;Texas Spine Care Center is a San Antonio-based orthopedic spine practice with two locations focused exclusively on spine care. The practice joins existing CLARITY sites including Johns Hopkins University, Northwestern Medicine, Advocate Aurora Research Institute, Texas Back Institute, Keck Medicine at USC, UHealth — University of Miami Health System, Scripps Health, and Lanman Spinal Neurosurgery.&lt;/p&gt;&lt;p&gt;&quot;Too often in spine care, we treat</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Aclarion+adds+Texas+Spine+Care+Center+to+CLARITY+trial+network/26738223.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:02:07 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Aclarion Announces Texas Spine Care Center as New CLARITY Site</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient&amp;apos;s pain before recommending treatment&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain &lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;em&gt;Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;BROOMFIELD, Colo., July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=K6rzesSSjgZRyU4C13KKOp5lZkkaaaPTI2rBKRpu45_aEHd4EoLAKeVzbB0d-XApxIyJwTAfcLgOnTga5doE9w==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Aclarion, Inc&lt;/a&gt;., &lt;strong&gt;(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), &lt;/strong&gt;a healthcare technology company that is leveraging</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Texas+Spine+Care+Center+as+New+CLARITY+Site/26738191.html</guid>
   <pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07784124</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.08435063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACONW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00073229</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20032280</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  4          Aclarion, Inc.            For: Jun 11  Filed by: Deitsch Stephen</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Deitsch+Stephen/26641371.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641371.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Deitsch+Stephen/26641371.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  4          Aclarion, Inc.            For: Jun 11  Filed by: Deitsch Stephen</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Deitsch+Stephen/26641371.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641371.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Deitsch+Stephen/26641371.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  4          Aclarion, Inc.            For: Jun 11  Filed by: Thramann Jeffrey John</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Thramann+Jeffrey+John/26641372.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641372.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Thramann+Jeffrey+John/26641372.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  4          Aclarion, Inc.            For: Jun 11  Filed by: Thramann Jeffrey John</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Thramann+Jeffrey+John/26641372.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641372.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Thramann+Jeffrey+John/26641372.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  4          Aclarion, Inc.            For: Jun 11  Filed by: Neal David K</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Neal+David+K/26641373.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641373.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Neal+David+K/26641373.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  4          Aclarion, Inc.            For: Jun 11  Filed by: Neal David K</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Neal+David+K/26641373.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641373.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Neal+David+K/26641373.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
  <item>
   <title>Form  4          Aclarion, Inc.            For: Jun 11  Filed by: Gould Gregory A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Gould+Gregory+A/26641379.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641379.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Jun+11++Filed+by%3A+Gould+Gregory+A/26641379.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACON</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54253988</category>
   	  </item>
 </channel>
</rss>
